Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Innate Pharma S.A. ADR (IPHA)

Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2024 Jun, 2024 Dec, 2023 Jun, 2023 Dec, 2022
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income 0 0 0 0 0
Net Income Growth unch unch unch unch unch

Balance Sheet

(Values in U.S. Thousands) Dec, 2024 Jun, 2024 Dec, 2023 Jun, 2023 Dec, 2022
Total Assets 105,500 120,180 163,150 199,350 217,040
Total Assets Growth -12.22% -26.34% -18.16% -8.15% -0.90%
Total Liabilities 99,660 110,620 132,140 143,180 153,950
Total Liabilities Growth -9.91% -16.29% -7.71% -7.00% -4.94%

Cash Flow

(Values in U.S. Thousands) Dec, 2024 Jun, 2024 Dec, 2023 Jun, 2023 Dec, 2022
Operating Cash Flow -35,380 -7,460 3,270 -35,240 -12,500
Operating Cash Flow Growth -374.26% -328.13% +109.28% -181.92% +38.06%
Net Cash Flow -14,410 -4,560 -660 -14,740 -13,970
Change in Net Cash Flow -216.01% -590.91% +95.52% -5.51% +32.12%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot